Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aurelia, Bustos"'
Autor:
Aurelia Bustos, Artemio Payá, Andrés Torrubia, Rodrigo Jover, Xavier Llor, Xavier Bessa, Antoni Castells, Ángel Carracedo, Cristina Alenda
Publikováno v:
Biomolecules, Vol 11, Iss 12, p 1786 (2021)
The prediction of microsatellite instability (MSI) using deep learning (DL) techniques could have significant benefits, including reducing cost and increasing MSI testing of colorectal cancer (CRC) patients. Nonetheless, batch effects or systematic b
Externí odkaz:
https://doaj.org/article/2ba57efdc6dc4dd1b306e120b7f94fca
The prediction of microsatellite instability (MSI) in colorectal cancer (CRC) using deep learning (DL) techniques directly from hematoxylin and eosin stained slides (H&E) has been shown feasible by independent works. Nonetheless, when available, rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d20519012d4bc478c8198ae4adcf7bb
https://doi.org/10.1101/2022.12.29.22284034
https://doi.org/10.1101/2022.12.29.22284034
Autor:
Aurelia Bustos, Antonio Pertusa
Publikováno v:
Applied Sciences, Vol 8, Iss 7, p 1206 (2018)
Interventional cancer clinical trials are generally too restrictive, and some patients are often excluded on the basis of comorbidity, past or concomitant treatments, or the fact that they are over a certain age. The efficacy and safety of new treatm
Externí odkaz:
https://doaj.org/article/17c161453fe042b0a469faea5fbd0d6f
Publikováno v:
RUA. Repositorio Institucional de la Universidad de Alicante
Universidad de Alicante (UA)
Universidad de Alicante (UA)
We present a labeled large-scale, high resolution chest x-ray dataset for the automated exploration of medical images along with their associated reports. This dataset includes more than 160,000 images obtained from 67,000 patients that were interpre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddcb823742c5a2ab953085b028dd5623
Autor:
Antonio Pertusa, Aurelia Bustos
Publikováno v:
RUA. Repositorio Institucional de la Universidad de Alicante
Universidad de Alicante (UA)
Applied Sciences
Volume 8
Issue 7
Applied Sciences, Vol 8, Iss 7, p 1206 (2018)
Universidad de Alicante (UA)
Applied Sciences
Volume 8
Issue 7
Applied Sciences, Vol 8, Iss 7, p 1206 (2018)
Interventional cancer clinical trials are generally too restrictive, and some patients are often excluded on the basis of comorbidity, past or concomitant treatments, or the fact that they are over a certain age. The efficacy and safety of new treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a46ef2256cac8f42f56bfcd90091665c
https://hdl.handle.net/10045/77751
https://hdl.handle.net/10045/77751
Autor:
Aurelia, Bustos, Ruth, Álvarez, Pedro Miguel, Aramburo, Francisco, Carabantes, Nieves, Díaz, Jesús, Florián, Martín, Lázaro, José María Martín, de Segovia, José Antonio, Gasquet, Adrián, Alegre, Javier, Dorta
Publikováno v:
Current Medical Research and Opinion. 28:57-67
To investigate the patterns of use of darbepoetin alfa in Spanish centers, and to evaluate its effectiveness in the treatment of chemotherapy-induced anemia under clinical practice conditions.This was an observational, retrospective, multicenter stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bee13555a196534ff37180a886b1124
https://doi.org/10.1185/03007995.2011.639352
https://doi.org/10.1185/03007995.2011.639352
Autor:
Aurelia Bustos, M. Rivas, Cristiane M Nascimento, Francisco J. Martín Fernández, Manolis Kogevinas, Francisco X. Real, Diana Puente, Núria Malats
Publikováno v:
The Lancet. Oncology. 6(9)
Summary Background P53 is the most widely investigated molecular marker in bladder cancer. We aimed to review comprehensively the evidence for use of changes in P53 to predict bladder-cancer recurrence, progression, and mortality. Methods We reviewed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263a872b1956ff24e0a7ed2cf983777a
https://pubmed.ncbi.nlm.nih.gov/16129368
https://pubmed.ncbi.nlm.nih.gov/16129368
Publikováno v:
Journal of Clinical Oncology. 28:e16531-e16531
e16531 Background: Hospital-Based Cancer Registries (HBCRs) are key tools to plan and monitor the quality of care and outcome of cancer patients. However, data regarding the utility of HBCR in cancer services is limited. This study describes the rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c192157836cfb465ca23d3a979c1252
https://doi.org/10.1200/jco.2010.28.15_suppl.e16531
https://doi.org/10.1200/jco.2010.28.15_suppl.e16531
3074 Darbepoetin alfa for the treatment of chemotherapy-induced anemia in patients with solid tumors
Autor:
M. Lázaro, Aurelia Bustos, F. Carabantes, P. Bueso, A. Alegre, Nieves Díaz, J. A. Gasquet, R. Alvarez
Publikováno v:
European Journal of Cancer Supplements. 7:197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae8923e986e463d394f8edc48e151de6
https://doi.org/10.1016/s1359-6349(09)70673-1
https://doi.org/10.1016/s1359-6349(09)70673-1
Autor:
M. A. Cruz, A. Alegre, J. M. Martín de Segovia, Nieves Díaz, J. Florián, Aurelia Bustos, M.T. Lázaro, F. Carabantes, P. Aramburo, J. A. Gasquet
Publikováno v:
Journal of Clinical Oncology. 27:e20585-e20585
e20585 Background: Chemotherapy-induced anemia (CIA) is a frequent complication of patients (pts) with cancer and could be treated with erythropoiesis-stimulating agents such darbepoetin alfa (DA). The aim of this study was to investigate the pattern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15246974e38983f48fb816f017a39b64
https://doi.org/10.1200/jco.2009.27.15_suppl.e20585
https://doi.org/10.1200/jco.2009.27.15_suppl.e20585